These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15787961)

  • 1. De novo design of a pentameric coiled-coil: decoding the motif for tetramer versus pentamer formation in water-soluble phospholamban.
    Slovic AM; Lear JD; DeGrado WF
    J Pept Res; 2005 Mar; 65(3):312-21. PubMed ID: 15787961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-ray structure of a water-soluble analog of the membrane protein phospholamban: sequence determinants defining the topology of tetrameric and pentameric coiled coils.
    Slovic AM; Stayrook SE; North B; Degrado WF
    J Mol Biol; 2005 May; 348(3):777-87. PubMed ID: 15826670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational design of a water-soluble analog of phospholamban.
    Slovic AM; Summa CM; Lear JD; DeGrado WF
    Protein Sci; 2003 Feb; 12(2):337-48. PubMed ID: 12538897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removing an interhelical salt bridge abolishes coiled-coil formation in a de novo designed peptide.
    Meier M; Lustig A; Aebi U; Burkhard P
    J Struct Biol; 2002; 137(1-2):65-72. PubMed ID: 12064934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering of the hydrophobic core of an alpha-helical coiled coil.
    Kiyokawa T; Kanaori K; Tajima K; Tanaka T
    Biopolymers; 2000; 55(5):407-14. PubMed ID: 11241216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and dynamics of phospholamban in solution and in membrane bilayer: computer simulations.
    Houndonougbo Y; Kuczera K; Jas GS
    Biochemistry; 2005 Feb; 44(6):1780-92. PubMed ID: 15697203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of phospholamban into a soluble pentameric helical bundle.
    Li H; Cocco MJ; Steitz TA; Engelman DM
    Biochemistry; 2001 Jun; 40(22):6636-45. PubMed ID: 11380258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling of a five-stranded coiled coil structure for the assembly domain of the cartilage oligomeric matrix protein.
    Kajava AV
    Proteins; 1996 Feb; 24(2):218-26. PubMed ID: 8820488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Core residue replacements cause coiled-coil orientation switching in vitro and in vivo: structure-function correlations for osmosensory transporter ProP.
    Tsatskis Y; Kwok SC; Becker E; Gill C; Smith MN; Keates RA; Hodges RS; Wood JM
    Biochemistry; 2008 Jan; 47(1):60-72. PubMed ID: 18076193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward a high-resolution structure of phospholamban: design of soluble transmembrane domain mutants.
    Frank S; Kammerer RA; Hellstern S; Pegoraro S; Stetefeld J; Lustig A; Moroder L; Engel J
    Biochemistry; 2000 Jun; 39(23):6825-31. PubMed ID: 10841762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the minimum size of a hydrophobic cluster in two-stranded alpha-helical coiled-coils: effects on protein stability.
    Lu SM; Hodges RS
    Protein Sci; 2004 Mar; 13(3):714-26. PubMed ID: 14978309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide inhibitors use two related mechanisms to alter the apparent calcium affinity of the sarcoplasmic reticulum calcium pump.
    Afara MR; Trieber CA; Ceholski DK; Young HS
    Biochemistry; 2008 Sep; 47(36):9522-30. PubMed ID: 18702513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational transition between four and five-stranded phenylalanine zippers determined by a local packing interaction.
    Liu J; Zheng Q; Deng Y; Kallenbach NR; Lu M
    J Mol Biol; 2006 Aug; 361(1):168-79. PubMed ID: 16828114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane binding and structure of de novo designed alpha-helical cationic coiled-coil-forming peptides.
    Vagt T; Zschörnig O; Huster D; Koksch B
    Chemphyschem; 2006 Jun; 7(6):1361-71. PubMed ID: 16680794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving coiled-coil stability by optimizing ionic interactions.
    Burkhard P; Ivaninskii S; Lustig A
    J Mol Biol; 2002 May; 318(3):901-10. PubMed ID: 12054832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the 1-36 amino-terminal fragment of human phospholamban by nuclear magnetic resonance and modeling of the phospholamban pentamer.
    Pollesello P; Annila A; Ovaska M
    Biophys J; 1999 Apr; 76(4):1784-95. PubMed ID: 10096878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramolecular charge interactions as a tool to control the coiled-coil-to-amyloid transformation.
    Pagel K; Wagner SC; Rezaei Araghi R; von Berlepsch H; Böttcher C; Koksch B
    Chemistry; 2008; 14(36):11442-51. PubMed ID: 19016556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinking the coiled coil--negatively charged residues at the coiled-coil interface.
    Straussman R; Ben-Ya'acov A; Woolfson DN; Ravid S
    J Mol Biol; 2007 Mar; 366(4):1232-42. PubMed ID: 17207815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics studies on structure and dynamics of phospholamban monomer and pentamer in membranes.
    Kim T; Lee J; Im W
    Proteins; 2009 Jul; 76(1):86-98. PubMed ID: 19089978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational specificity of the lac repressor coiled-coil tetramerization domain.
    Liu J; Zheng Q; Deng Y; Li Q; Kallenbach NR; Lu M
    Biochemistry; 2007 Dec; 46(51):14951-9. PubMed ID: 18052214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.